Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

(JACC: Asia) Cryptogenic strokes in adults under ... (Heart) Compared with men, women with abdominal aortic aneurysm were typically diagnosed almost a decade later and underwent repair less ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients: Galway, Ireland Tuesday, April 1 ...

Medtronic (MDT) announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut ...

The American College of Cardiology has recognized 10 young researchers with the Young Author Achievement Award, due to their outstanding research published in the JACC family of journals. All ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR ... Expo and simultaneously published in the JACC, the flagship journal of the American College of Cardiology.